UPL Past Earnings Performance
Past criteria checks 0/6
UPL's earnings have been declining at an average annual rate of -20.5%, while the Chemicals industry saw earnings growing at 14.6% annually. Revenues have been growing at an average rate of 7.8% per year.
Key information
-20.5%
Earnings growth rate
-18.9%
EPS growth rate
| Chemicals Industry Growth | 17.7% |
| Revenue growth rate | 7.8% |
| Return on equity | -8.9% |
| Net Margin | -4.9% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How UPL makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 441,220 | -21,400 | 58,950 | 0 |
| 30 Jun 24 | 432,020 | -18,860 | 56,950 | 0 |
| 31 Mar 24 | 430,980 | -13,360 | 55,740 | 0 |
| 31 Dec 23 | 455,890 | -5,830 | 61,940 | 0 |
| 30 Sep 23 | 493,810 | 17,210 | 63,540 | 0 |
| 30 Jun 23 | 517,180 | 27,240 | 63,480 | 0 |
| 31 Mar 23 | 535,760 | 34,350 | 63,220 | 0 |
| 31 Dec 22 | 528,680 | 40,360 | 60,120 | 0 |
| 30 Sep 22 | 504,860 | 38,850 | 58,240 | 0 |
| 30 Jun 22 | 485,460 | 37,050 | 56,780 | 0 |
| 31 Mar 22 | 462,400 | 35,050 | 53,940 | 0 |
| 31 Dec 21 | 431,750 | 32,200 | 47,520 | 0 |
| 30 Sep 21 | 410,040 | 30,780 | 46,110 | 0 |
| 30 Jun 21 | 393,760 | 29,070 | 44,290 | 0 |
| 31 Mar 21 | 386,940 | 27,810 | 43,570 | 0 |
| 31 Dec 20 | 370,390 | 24,250 | 44,650 | 0 |
| 30 Sep 20 | 368,050 | 23,390 | 41,930 | 0 |
| 30 Jun 20 | 356,830 | 20,420 | 34,000 | 0 |
| 31 Mar 20 | 357,560 | 17,760 | 40,910 | 0 |
| 31 Dec 19 | 331,400 | 13,650 | 36,440 | 0 |
| 30 Sep 19 | 291,690 | 9,340 | 34,170 | 0 |
| 30 Jun 19 | 256,090 | 11,150 | 25,020 | 0 |
| 31 Mar 19 | 218,370 | 14,910 | 26,050 | 0 |
| 31 Dec 18 | 190,030 | 19,770 | 22,390 | 0 |
| 30 Sep 18 | 182,760 | 20,900 | 21,600 | 0 |
| 30 Jun 18 | 177,890 | 20,590 | 21,390 | 0 |
| 31 Mar 18 | 173,780 | 20,220 | 20,970 | 0 |
| 31 Dec 17 | 170,290 | 20,270 | 21,470 | 0 |
| 30 Sep 17 | 167,540 | 19,120 | 21,450 | 0 |
| 30 Jun 17 | 165,250 | 18,400 | 20,980 | 0 |
| 31 Mar 17 | 163,120 | 17,270 | 20,610 | 0 |
| 31 Dec 16 | 146,180 | 15,473 | 17,197 | 0 |
| 30 Sep 16 | 140,163 | 13,692 | 16,477 | 0 |
| 30 Jun 16 | 135,366 | 13,840 | 15,884 | 0 |
| 31 Mar 16 | 140,480 | 9,400 | 18,170 | 0 |
| 31 Dec 15 | 125,861 | 11,913 | 23,977 | 37 |
| 30 Sep 15 | 125,370 | 11,538 | 23,595 | 37 |
| 30 Jun 15 | 123,978 | 11,347 | 23,357 | 37 |
| 31 Mar 15 | 120,905 | 11,485 | 12,866 | 0 |
| 31 Dec 14 | 118,353 | 10,725 | 21,058 | 116 |
| 30 Sep 14 | 114,299 | 10,455 | 21,037 | 116 |
| 30 Jun 14 | 108,905 | 10,341 | 9,724 | 0 |
| 31 Mar 14 | 107,709 | 9,581 | 20,579 | 116 |
| 31 Dec 13 | 102,404 | 8,679 | 18,825 | 183 |
Quality Earnings: 512070 is currently unprofitable.
Growing Profit Margin: 512070 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 512070 is unprofitable, and losses have increased over the past 5 years at a rate of 20.5% per year.
Accelerating Growth: Unable to compare 512070's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 512070 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (8%).
Return on Equity
High ROE: 512070 has a negative Return on Equity (-8.85%), as it is currently unprofitable.